| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 222 |
| 1 | RANITIDINE HYDROCHLORIDE | 170 |
| 2 | METHOTREXATE SODIUM | 26 |
| 3 | ADALIMUMAB | 23 |
| 4 | METHOTREXATE | 21 |
| 5 | PREDNISONE | 21 |
| 6 | CYCLOPHOSPHAMIDE | 19 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 19 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 19 |
| 9 | ETANERCEPT | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RANITIDINE HYDROCHLORIDE | 170 | 0.0031 |
| 1 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 2 | RANITIDINE | 222 | 0.0011 |
| 3 | METYRAPONE | 1 | 0.0010 |
| 4 | PENTOSTATIN | 1 | 0.0010 |
| 5 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 6 | SODIUM CITRATE | 1 | 0.0008 |
| 7 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| 8 | GLYCEROL PHENYLBUTYRATE | 1 | 0.0007 |
| 9 | LEMBOREXANT | 2 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 39 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 36 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 3 | Alkylating Drug [EPC] | 21 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 21 |
| 5 | Kinase Inhibitor [EPC] | 19 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 18 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 17 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 14 |
| 9 | Benzodiazepine [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 14 | 0.0007 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 6 | Calcitonin [EPC] | 1 | 0.0003 |
| 7 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 8 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 9 | GLP-2 Analog [EPC] | 3 | 0.0002 |